# OnCo record emergence-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/emergence-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "emergence-therapeutics" ;
  schema:name "Emergence Therapeutics"@en ;
  schema:description "Emergence Therapeutics was a German start-up making an antibody that carries a cancer-killing drug to a protein called Nectin-4, which is found on most bladder cancers. Eli Lilly bought the company in 2023."@en ;
  schema:url <https://onco.cc/companies/emergence-therapeutics/>, <https://www.lilly.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.lilly.com/>, <https://www.biopharmadive.com/news/lilly-acquire-emergence-adc-cancer-drugs/654326/> ;
  schema:addressCountry "DE" ;
  onco:related <https://onco.cc/collections/src-biopharma-dive/> ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/nectin4/> .